|
1
|
Moertel CG, Fleming TR, Rubin J, Kvols LK,
Sarna G, Koch R, Currie VE, Young CW, Jones SE and Davignon JP: A
clinical trial of amygdalin (laetrile) in the treatment of human
cancer. N Engl J Med. 306:201–206. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Newell GR and Ellison NM: Ethics and
designs: laetrile trials as an example. Cancer Treat Rep.
64:363–365. 1980.PubMed/NCBI
|
|
3
|
van Zijl F, Krupitza G and Mikulits W:
Initial steps of metastasis: cell invasion and endothelial
transmigration. Mutat Res. 728:23–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun CC, Qu XJ and Gao ZH: Integrins:
players in cancer progression and targets in cancer therapy.
Anticancer Drugs. 25:1107–1121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Makarević J, Rutz J, Juengel E, Kaulfuss
S, Tsaur I, Nelson K, Pfitzenmaier J, Haferkamp A and Blaheta RA:
Amygdalin influences bladder cancer cell adhesion and invasion in
vitro. PLoS One. 9:e1102442014. View Article : Google Scholar
|
|
6
|
Makarević J, Rutz J, Juengel E, Kaulfuss
S, Reiter M, Tsaur I, Bartsch G, Haferkamp A and Blaheta RA:
Amygdalin blocks bladder cancer cell growth in vitro by diminishing
cyclin A and cdk2. PLoS One. 9:e1055902014. View Article : Google Scholar
|
|
7
|
Salvo E, Garasa S, Dotor J, Morales X,
Peláez R, Altevogt P and Rouzaut A: Combined targeting of TGF-β1
and integrin β3 impairs lymph node metastasis in a mouse model of
non-small-cell lung cancer. Mol Cancer. 13:1122014. View Article : Google Scholar
|
|
8
|
White NM, Masui O, Newsted D, Scorilas A,
Romaschin AD, Bjarnason GA, Siu KW and Yousef GM: Galectin-1 has
potential prognostic significance and is implicated in clear cell
renal cell carcinoma progression through the HIF/mTOR signaling
axis. Br J Cancer. 110:1250–1259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Juengel E, Makarević J, Reiter M, Mani J,
Tsaur I, Bartsch G, Haferkamp A and Blaheta RA: Resistance to the
mTOR inhibitor temsirolimus alters adhesion and migration behavior
of renal cell carcinoma cells through an integrin α5- and integrin
β3-dependent mechanism. Neoplasia. 16:291–300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsaur I, Makarević J, Juengel E, Gasser M,
Waaga-Gasser AM, Kurosch M, Reiter M, Wedel S, Bartsch G, Haferkamp
A, et al: Resistance to the mTOR-inhibitor RAD001 elevates integrin
α2- and β1-triggered motility, migration and invasion of prostate
cancer cells. Br J Cancer. 107:847–855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Imanishi Y, Hu B, Jarzynka MJ, Guo P,
Elishaev E, Bar-Joseph I and Cheng SY: Angiopoietin-2 stimulates
breast cancer metastasis through the alpha(5)beta(1)
integrin-mediated pathway. Cancer Res. 67:4254–4263. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitra AK, Sawada K, Tiwari P, Mui K, Gwin
K and Lengyel E: Ligand-independent activation of c-Met by
fibronectin and α(5) β(1)-integrin regulates ovarian cancer
invasion and metastasis. Oncogene. 30:1566–1576. 2011. View Article : Google Scholar :
|
|
13
|
Lityńska A, Przybyło M, Pocheć E and
Laidler P: Adhesion properties of human bladder cell lines with
extracellular matrix components: the role of integrins and
glycosylation. Acta Biochim Pol. 49:643–650. 2002.
|
|
14
|
Ricci E, Mattei E, Dumontet C, Eaton CL,
Hamdy F, van der Pluije G, Cecchini M, Thalmann G, Clezardin P and
Colombel M: Increased expression of putative cancer stem cell
markers in the bone marrow of prostate cancer patients is
associated with bone metastasis progression. Prostate.
73:1738–1746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chao C, Lotz MM, Clarke AC and Mercurio
AM: A function for the integrin alpha6beta4 in the invasive
properties of colorectal carcinoma cells. Cancer Res. 56:4811–4819.
1996.PubMed/NCBI
|
|
16
|
Cruz-Monserrate Z and O'Connor KL:
Integrin alpha 6 beta 4 promotes migration, invasion through Tiam1
upregulation, and subsequent Rac activation. Neoplasia. 10:408–417.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim TH, Kim HI, Soung YH, Shaw LA and
Chung J: Integrin (alpha6beta4) signals through Src to increase
expression of S100A4, a metastasis-promoting factor: implications
for cancer cell invasion. Mol Cancer Res. 7:1605–1612. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang XH, Flores LM, Li Q, Zhou P, Xu F,
Krop IE and Hemler ME: Disruption of laminin-integrin-CD151-focal
adhesion kinase axis sensitizes breast cancer cells to ErbB2
antagonists. Cancer Res. 70:2256–2263. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee S, Qiao J, Paul P and Chung DH:
Integrin β1 is critical for gastrin-releasing peptide
receptor-mediated neuroblastoma cell migration and invasion.
Surgery. 154:369–375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khalili P, Arakelian A, Chen G, Plunkett
ML, Beck I, Parry GC, Doñate F, Shaw DE, Mazar AP and Rabbani SA: A
non-RGD-based integrin binding peptide (ATN-161) blocks breast
cancer growth and metastasis in vivo. Mol Cancer Ther. 5:2271–2280.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsaur I, Rutz J, Makarević J, Juengel E,
Gust KM, Borgmann H, Schilling D, Nelson K, Haferkamp A, Bartsch G
and Blaheta RA: CCL2 promotes integrin-mediated adhesion of
prostate cancer cells in vitro. World J Urol. 33:1051–1056. 2015.
View Article : Google Scholar
|
|
22
|
Zutter MM, Santoro SA, Staatz WD and Tsung
YL: Re-expression of the alpha 2 beta 1 integrin abrogates the
malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci
USA. 92:7411–7415. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cagnet S, Faraldo MM, Kreft M, Sonnenberg
A, Raymond K and Glukhova MA: Signaling events mediated by α3β1
integrin are essential for mammary tumorigenesis. Oncogene.
33:4286–4295. 2014. View Article : Google Scholar
|
|
24
|
Lee S, Qiao J, Paul P, O'Connor KL, Evers
MB and Chung DH: FAK is a critical regulator of neuroblastoma liver
metastasis. Oncotarget. 3:1576–1587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tringali C, Lupo B, Silvestri I, Papini N,
Anastasia L, Tettamanti G and Venerando B: The plasma membrane
sialidase NEU3 regulates the malignancy of renal carcinoma cells by
controlling β1 integrin internalization and recycling. J Biol Chem.
287:42835–42845. 2012. View Article : Google Scholar : PubMed/NCBI
|
